Literature DB >> 22930510

Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis.

Massimo Ciccozzi1, Michele Equestre, Angela Costantino, Nadia Marascio, Angela Quirino, Alessandra Lo Presti, Eleonora Cella, Roberto Bruni, Maria Carla Liberto, Alfredo Focà, Giulio Pisani, Gianguglielmo Zehender, Anna Rita Ciccaglione.   

Abstract

Hepatitis C Virus (HCV) genotype 4 predominates in Middle East and Central Africa countries. Recently, it has become also prevalent in Southern European countries where it is thought to have been introduced through immigration and the movement of intravenous drug users. In Italy, the prevalence of genotype 4 is particularly high (4.5%) in Southern regions, such as Calabria, and reaches values of 8.4% in specific areas where there appears to be endemic circulation of this genotype. In the present study, the phylogeny of HCV subtype 4d isolated from 19 Italian patients in Calabria was investigated by analysing a fragment of the NS5B viral genomic region. A Bayesian coalescent-based framework was used to estimate origin and spread of the HCV 4d in this area. The mean evolutionary rate HCV 4d NS5B sequences was estimated using a dataset of sequences sampled at known times and a relaxed clock constant model that best fitted the data. By using a Bayesian coalescent method, the Italian 4d isolates collected in Calabria were found to share a common ancestor with reference 4d isolates whose origin was traced back to 1940s. The genotype 4d epidemic in Southern Italy was maintained in a steady non-expanding phase until the late 1970s after that it grew exponentially up to 1990s probably sustained by the vast increase of unsafe blood transfusions and the spread of illicit intravenous drug users.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930510     DOI: 10.1002/jmv.23384

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

Review 1.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages.

Authors:  Ling Lu; Yan Xu; Jie Yuan; Chunhua Li; Donald G Murphy
Journal:  Virology       Date:  2015-04-05       Impact factor: 3.616

3.  Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS.

Authors:  Samantha L Strickland; Brittany D Rife; Susanna L Lamers; David J Nolan; Nazle M C Veras; Mattia C F Prosperi; Tricia H Burdo; Patrick Autissier; Brian Nowlin; Maureen M Goodenow; Marc A Suchard; Kenneth C Williams; Marco Salemi
Journal:  J Gen Virol       Date:  2014-09-09       Impact factor: 3.891

Review 4.  Update on different aspects of HCV variability: focus on NS5B polymerase.

Authors:  Nadia Marascio; Carlo Torti; Maria Liberto; Alfredo Focà
Journal:  BMC Infect Dis       Date:  2014-09-05       Impact factor: 3.090

5.  The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia.

Authors:  Ahmed A Al-Qahtani; Guy Baele; Nisreen Khalaf; Marc A Suchard; Mashael R Al-Anazi; Ayman A Abdo; Faisal M Sanai; Hamad I Al-Ashgar; Mohammed Q Khan; Mohammed N Al-Ahdal; Philippe Lemey; Bram Vrancken
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

Review 6.  Phylogeny and phylodinamic of Hepatitis C in Italy.

Authors:  Massimo Ciccozzi; Alessandra Lo Presti; Anna Rita Ciccaglione; Gianguglielmo Zehender; Marco Ciotti
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

7.  Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa.

Authors:  James C Iles; Jayna Raghwani; G L Abby Harrison; Jacques Pepin; Cyrille F Djoko; Ubald Tamoufe; Matthew LeBreton; Bradley S Schneider; Joseph N Fair; Felix M Tshala; Patrick K Kayembe; Jean Jacques Muyembe; Samuel Edidi-Basepeo; Nathan D Wolfe; Peter Simmonds; Paul Klenerman; Oliver G Pybus
Journal:  Virology       Date:  2014-08-06       Impact factor: 3.616

8.  Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients.

Authors:  Nadia Marascio; Grazia Pavia; Alessio Strazzulla; Tim Dierckx; Lize Cuypers; Bram Vrancken; Giorgio Settimo Barreca; Teresa Mirante; Donatella Malanga; Duarte Mendes Oliveira; Anne-Mieke Vandamme; Carlo Torti; Maria Carla Liberto; Alfredo Focà
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

9.  Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.

Authors:  Angela Costantino; Enea Spada; Michele Equestre; Roberto Bruni; Elena Tritarelli; Nicola Coppola; Caterina Sagnelli; Evangelista Sagnelli; Anna Rita Ciccaglione
Journal:  Virol J       Date:  2015-11-14       Impact factor: 4.099

10.  Genetic diversity of hepatitis C virus in Ethiopia.

Authors:  Gadissa Bedada Hundie; V Stalin Raj; Daniel GebreMichael; Suzan D Pas; Bart L Haagmans
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.